EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma

Zhonglong Liu, Xiaoyan Meng, Xiao Tang, Weili Zou, Yue He

Cancer Immunology, Immunotherapy · 2023-06 · 72 (6) · 1505-1521

DOI: 10.1007/s00262-022-03310-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 08.12.2022. Verfasst von Zhonglong Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Med…. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Head and Neck Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tertiary lymphoid structures (TLSs) hold the potential role in the prediction of immunotherapy response in several clinical trials. TLSs in head neck squamous cell carcinoma (HNSCC) have been investigated through IHC analysis, whereas there is no TLS gene signature to evaluate the level of TLS neogenesis. We here proposed a TLS signature containing 13 chemokines and determined TLS-hi and TLS-low groups in HNSCC samples from The Cancer Genome Atlas. TLS-hi condition signified a better overall survival. A more inflamed immune infiltrative landscape was identified in the TLS-hi tumors characterized by higher proportion of T cells, TCR/BCR activation and antigen processing. High level of TLSs has a determined role in the clinical significance of T cells. Interesting discovery was that innate lymphoid cells and cancer-associated fibroblasts were positively associated with TLS neogenesis in TME of HNSCC. Furthermore, by integrated TLSs with stromal cells and score, immune cells and score, TMB and malignant cells, we proposed a novel HNSCC TME classifications (HNSCC-TCs 1–5), unravelling the counteracted role of stromal cells and score in inflamed immune landscape, which may provide a novel stromal targeted modality in HNSCC therapy. Finally, we verified that TLS statue is an ideal predictor for immune checkpoint blockade immunotherapy. Current study indicated that the TLSs serve as a novel prognostic biomarker and predictor for immunotherapy, which may provide directions to the current investigations on immunotherapeutic strategies for HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Lymphoid StructuresHead and Neck NeoplasmsHumansImmunity, InnateLymphocytesSquamous Cell Carcinoma of Head and NeckImmunotherapyPrognosisTumor Microenvironment

Stichwörter der Autor:innen

HNSCCImmune landscapeImmunotherapyPrognosisTME classificationTertiary lymphoid structures (TLSs)

Autor:innen und Institutionen

  • Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, National Center of Stomatology, National Clinical Research Cent…
  • Suzhou Lingdian Biotechnology Co., Ltd, Suzhou, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Liu, Z., Meng, X., Tang, X., Zou, W., & He, Y. (2023). Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Cancer Immunology, Immunotherapy, 72(6), 1505-1521. https://doi.org/10.1007/s00262-022-03310-5

Vancouver

Liu Z, Meng X, Tang X, Zou W, He Y. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Cancer Immunology, Immunotherapy. 2023;72(6):1505-1521. doi:10.1007/s00262-022-03310-5

BibTeX
@article{Liu2023,
  author = {Liu, Zhonglong and Meng, Xiaoyan and Tang, Xiao and Zou, Weili and He, Yue},
  title = {Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2023},
  volume = {72},
  number = {6},
  pages = {1505--1521},
  doi = {10.1007/s00262-022-03310-5}
}
Kostenlos starten →